NPC1 and nasopharyngeal carcinoma: They exhibited distinct expression patterns of marker genes (Figure 3B), and sevoflurane could induce changes in their proportions: NPC‐S1 subtype increased in the sevoflurane‐treated group, while NPC‐S2 subtype decreased in the treated group.